Purnadeo N Persaud1, Xhilda Xhemali2, Kristen Neuhaus2
1Cleveland Clinic Foundation, Department of Internal Medicine, Cleveland, Ohio, USA.
Cefiderocol (FDC) shows promise in treating multidrug-resistant infections in lung transplant recipients (LTRs). This study highlights its effectiveness against resistant Pseudomonas aeruginosa, though further research is needed.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science: